top of page


Leukemia, a dangerous disease, is difficult to treat. Comparison of survival statistics after treatment in the CIS countries and Turkey:

  • in the CIS countries with leukemia, the 5-year survival rate is only 40-50%.

In Turkey, the chances of salvation are above 70%;

  • in hospitals in the CIS countries, acute lymphoblastic leukemia (more common in children) is treatable only 60% of children.

In Turkish clinics, 95% of patients under 20 live for more than 5 years.



The main goal of therapy is to destroy the maximum number of leukemic cells, as well as to achieve a stable remission in the patient. The success of treatment often depends on age: patients from 1 to 10 years old have the most favorable prognosis.

  • preparatory therapy

Therapy of lymphoblastic or myeloid leukemia in Turkish clinics involves several stages, carried out with great care, therefore, first, oncologists carry out preparatory treatment. This is a weekly course of chemotherapy in order to assess the body's response to treatment and to plan the intensity of therapy.

  • induction

After preparing a safe therapy protocol, a course of intensive chemotherapy is applied for a duration of 5 to 7 weeks. In the process, they try to bring the patient into remission.

  • consolidation therapy

The third stage, in order to prevent neuroleukemia and consolidate the state of remission, is prescribed new drugs for chemotherapy or a course of radiation therapy.

  • re-induction

To prevent the return of the disease, a 5-week course of intensive chemotherapy is repeated after a couple of months. The last remaining leukemia cells are destroyed, thus ending the main course of treatment for lymphoblastic or myeloid leukemia.

  • transplantation

If the course of high-dose chemotherapy has been able to kill almost all of the leukemia cells, and the patient is in remission, a bone marrow transplant can be performed. In the case of the possibility of drug treatment of acute leukemia, doctors try to choose it.

  • supportive therapy

After completing an intensive course of chemotherapy, the patient needs to undergo supportive therapy from weak courses of chemotherapy for another two years. This usually does not interfere with daily activities. If 5 years have passed without relapse since the start of therapy, then the patient is considered healthy.



Symptoms of leukemia may include:

  • weakness;

  • losing weight;

  • fever;

  • bone pain;

  • causeless hemorrhages4

  • lymphadenitis;

  • spleno- and hepatomegaly;

  • meningeal symptoms;

  • frequent infections.


As part of diagnostic studies for leukemia, a general and biochemical blood test, diagnostic puncture of the bone marrow (sternal) and spinal cord (lumbar), trepanobiopsy and biopsy of lymph nodes, radiography, ultrasound, CT and MRI of vital organs are performed. The key in leukemia is the study of bone marrow biopsies (myelogram) and cerebrospinal fluid, including morphological, cytogenetic, cytochemical and immunological analyzes. This makes it possible to clarify the forms and subtypes of leukemia, which is important for choosing a treatment protocol and predicting the disease.

Leukemic infiltration of internal organs is established by ultrasound of the lymph nodes, abdominal cavity and small pelvis, chest x-ray, skull, bones and joints, chest CT, MRI of the brain and spinal cord with contrast, echocardiography.


With leukemia, consultation with an otolaryngologist, neurologist, urologist, ophthalmologist is indicated.

Лечение лейкемии в Турции


  • Chemotherapy

  • Radiation therapy

  • Bone marrow transplant


Chemotherapy is the main treatment for myeloid and lymphoblastic leukemia. The treatment program consists of several courses of varying intensity in order to slow down the growth of leukemic cells and destroy existing ones.

Radiation therapy is needed to prevent neuroleukemia. When cancer blood cells penetrate into the brain or spinal cord by radiation, they are destroyed. Treatment is prescribed according to the protocol. In Turkey, the following protocols are used for the treatment of acute lymphoblastic leukemia in children: AIEOP-BFM ALL 2009, COALL-08-09, INTERFANT-06, SCTped 2012 FORUM, EsPhALL and others.


Treatment of leukemia requires long-term continuous polychemotherapy, symptomatic therapy, and, if necessary, bone marrow or stem cell transplantation.



It is very important to find a "quality" donor, this is possible thanks to access to the International Stem Cell Bank. This allows you to select a donor at a compatibility level of more than 90% in 2-3 months.

The cost of a bone marrow transplant is the most affordable to carry out the procedure in Turkish clinics, and it is the easiest to get to, plus an interpreter can be provided. The cost of autologous bone marrow transplant in Turkey is from $ 57,000.



All these clinics have passed JСI accreditation, and also comply with the most stringent international standards for the provision of medical services.



  • Chemotherapy from $ 1,500

  • Autologous BMT from $ 45,000

  • Allogeneic BMT from a relative donor from $ 60,000-80,000

  • BMT from an unrelated donor from $ 80,000-110,000

To organize blood cancer treatment in Turkey, leave a request on the Medikal & Estetik Group website. You will be contacted by a specialized doctor-coordinator who will help you choose the best medical center. Send him your medical records, he will redirect them to the hospital of your choice and request a treatment program.

We will help you organize your trip and stay in touch with you throughout your treatment - from the moment you contact us and even after you return home.

Medikal & Estetik Group is an independent medical service that does not represent the interests of any of the clinics. Patients do not pay for our services - medical centers do it.

Doctors-coordinators will advise you and help you with the choice. Medikal & Estetik Group services are free of charge for you and do not affect the clinic bill.

bottom of page